Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified del Nido vs Conventional Crystalloid Cardioplegia in Mitral Valve Surgery
NCT05797090Completed
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of modified del Nido cardioplegia in mitral valve regurgitation (MR). Primary endpoint: Myocardial protection at 24 hours. Started Jul 2022; status: completed.
02
Drugs
modified del Nido cardioplegia
03
Conditions
mitral valve regurgitation (MR)
Beyond the preview
Go deeper on NCT05797090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797090.